RELATED CONTENT
NEWS
- Idera holds out hope for IMO-2055 after negative Phase II head and neck cancer data
- Scotland says yes to BI/Lilly's Tradjenta and Lilly's Bydureon
- Phase III colorectal trial a landmark for Alchemia's lead cancer product
- Bayer submits US, European applications for regorafenib in mCRC
FEATURES
- Chinese producers may be losing price edge to India, says Granules MD
- Merck BioVentures: where biosimilars make a difference
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

